TOPOTECAN INJECTION DIN 02409232
Status: Cancelled Post Market
Holder: TEVA CANADA LIMITED
Molecule: TOPOTECAN (TOPOTECAN HYDROCHLORIDE)
Health Canada record
| Active ingredient(s) | TOPOTECAN (TOPOTECAN HYDROCHLORIDE) 1 MG |
|---|---|
| Dosage form | Solution |
| Route | Intravenous |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | L01CE01 TOPOTECAN |
| Original market date | 21-Oct-2013 |
| Current status date | 30-Jul-2021 |
| Source | Health Canada DPD |
Establishment licence of the holder
Teva Canada Limited — licence 101810, currently licensed, last inspection rating C (2025-03-04).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing TOPOTECAN (TOPOTECAN HYDROCHLORIDE)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02441071 | TEVA-TOPOTECAN | TEVA CANADA LIMITED | Powder For Solution | TOPOTECAN (TOPOTECAN HYDROCHLORIDE) 4 MG | Marketed |
| 02441063 | TEVA-TOPOTECAN | TEVA CANADA LIMITED | Powder For Solution | TOPOTECAN (TOPOTECAN HYDROCHLORIDE) 1 MG | Approved |
| 02396378 | TOPOTECAN HYDROCHLORIDE FOR INJECTION | ACCORD HEALTHCARE INC | Solution | TOPOTECAN (TOPOTECAN HYDROCHLORIDE) 1 MG | Marketed |
| 02344009 | TOPOTECAN HYDROCHLORIDE FOR INJECTION | ACCORD HEALTHCARE INC | Powder For Solution | TOPOTECAN (TOPOTECAN HYDROCHLORIDE) 4 MG | Approved |
| 02379422 | TOPOTECAN HYDROCHLORIDE FOR INJECTION | PFIZER CANADA ULC | Solution | TOPOTECAN (TOPOTECAN HYDROCHLORIDE) 1 MG | Marketed |
| 02390981 | TOPOTECAN INJECTION | SANDOZ CANADA INCORPORATED | Solution | TOPOTECAN (TOPOTECAN HYDROCHLORIDE) 1 MG | Marketed |
| 02231116 | HYCAMTIN | NOVARTIS PHARMACEUTICALS CANADA INC | Powder For Solution | TOPOTECAN (TOPOTECAN HYDROCHLORIDE) 4 MG | Cancelled Post Market |
| 02392798 | MYLAN-TOPOTECAN HYDROCHLORIDE FOR INJECTION | MYLAN PHARMACEUTICALS ULC | Powder For Solution | TOPOTECAN (TOPOTECAN HYDROCHLORIDE) 4 MG | Cancelled Pre Market |
| 02406438 | PMS-TOPOTECAN | PHARMASCIENCE INC | Powder For Solution | TOPOTECAN (TOPOTECAN HYDROCHLORIDE) 1 MG | Cancelled Pre Market |
| 02406446 | PMS-TOPOTECAN | PHARMASCIENCE INC | Powder For Solution | TOPOTECAN (TOPOTECAN HYDROCHLORIDE) 4 MG | Cancelled Post Market |
| 02346656 | TOPOTECAN FOR INJECTION | FRESENIUS KABI CANADA LTD | Powder For Solution | TOPOTECAN (TOPOTECAN HYDROCHLORIDE) 4 MG | Cancelled Post Market |
| 02333880 | TOPOTECAN FOR INJECTION | SANDOZ CANADA INCORPORATED | Powder For Solution | TOPOTECAN (TOPOTECAN HYDROCHLORIDE) 4 MG | Cancelled Post Market |
| 02396564 | TOPOTECAN HYDROCHLORIDE FOR INJECTION | MYLAN PHARMACEUTICALS ULC | Powder For Solution | TOPOTECAN (TOPOTECAN HYDROCHLORIDE) 4 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 14550 | 2013-07-16 | Abbreviated New Drug Submission (ANDS) |